Wiley.com

User login

Yoga Helps Patients with Ulcerative Colitis

Patients with ulcerative colitis, a chronic inflammatory bowel disease, often relapse at times of stress. In a clinical trial of 77 ulcerative colitis patients who were in clinical remission but were experiencing reduced quality of life, those assigned to 12 supervised 90-minute weekly sessions of yoga had a greater increase in quality of life and reduced activity of their colitis compared with those who were given written self-care advice.

Wednesday, April 5, 2017 12:01 am EDT
"Many people use yoga to increase their quality of life. Our study suggests that it might be worthwhile to consider yoga as part of a multimodal integrative approach for treating ulcerative colitis"

Patients with ulcerative colitis, a chronic inflammatory bowel disease, often relapse at times of stress. In a clinical trial of 77 ulcerative colitis patients who were in clinical remission but were experiencing reduced quality of life, those assigned to 12 supervised 90-minute weekly sessions of yoga had a greater increase in quality of life and reduced activity of their colitis compared with those who were given written self-care advice.

The findings suggest that regular yoga may be a valuable adjunct to conventional medical therapies for ulcerative colitis.

“Many people use yoga to increase their quality of life. Our study suggests that it might be worthwhile to consider yoga as part of a multimodal integrative approach for treating ulcerative colitis,” said Prof. Holger Cramer, lead author of the Alimentary Pharmacology & Therapeutics study.

 

Additional Information

Link to Studyhttp://doi.wiley.com/10.1111/apt.14062

About Journal

Alimentary Pharmacology & Therapeutics is an international journal of gastroenterology and hepatology.  

The journal accepts original papers and systematic reviews concerned with clinical gastroenterology, hepatology and endoscopy.
              
AP&T is particularly interested in therapies and diagnostics, including all aspects of translation from bench to bedside: identification of novel therapeutic targets, epidemiology, clinical trials, drug safety and meta-analyses.         

Multimedia Files:

Preview image

Contact:

Penny Smith
+44 (0) 1243 770448
sciencenewsroom@wiley.com